UNSPSC 51201900: Multiple sclerosis MS agents

This classification denotes drugs to treat an autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system, multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system, and visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction.

UNSPSC 51201900 Multiple sclerosis MS agents is a Class code under which state and local health departments procure vaccines and pharmaceutical agents for disease prevention and treatment programs. The single recent solicitation tagged to this code—a yellow fever vaccine procurement—represents a mismatch with the code's nominal scope of multiple sclerosis therapeutics, indicating that the code sees little relevant recent activity aligned with its intended product family. The Mississippi State Department of Health posted a sole source notice for Yellow Fever Vaccine from Sanofi Pasteur, Inc., on July 13, 2026, with objections due August 3, 2026 at 10:00 a.m. CST. The notice follows state procurement rules allowing challenge to sole source classification; any entity believing alternative vendors exist must submit written objection with supporting documentation to Cynthia Brasher at the Mississippi State Department of Health Purchasing Department by hand delivery, regular mail, overnight delivery, or email. The solicitation did not disclose quantity, contract term, or estimated value.

The geographic and issuing-body signals are limited: only Mississippi appears in the recent record. State health departments are the primary issuing body type under codes in this therapeutic family, though the single posted opportunity provides insufficient evidence of concentration, repeat buying patterns, or active market activity specific to MS agents. The mismatch between the code designation and the actual commodity (yellow fever vaccine) suggests that either the state's tagging practice does not align precisely with UNSPSC taxonomy, or that MS-agent procurement occurs through channels and notice types not reflected in this data block. Firms tracking this code should verify whether state and local opportunities in MS therapeutics are posted under alternative codes or cooperative purchasing vehicles not captured here.